Total Payments
$413.80
2024 Payments
$413.80
Companies
8
Transactions
19

Payment Breakdown by Category

Food & Beverage$413.80 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $413.80 19 100.0%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $86.74 4 $0 (2024)
Dendreon Pharmaceuticals LLC $68.57 2 $0 (2024)
Sumitomo Pharma America, Inc. $60.64 3 $0 (2024)
Merck Sharp & Dohme LLC $59.19 3 $0 (2024)
Eisai Inc. $50.99 3 $0 (2024)
Boston Scientific Corporation $45.22 2 $0 (2024)
Telix Pharmaceuticals $24.30 1 $0 (2024)
AstraZeneca Pharmaceuticals LP $18.15 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $413.80 19 PFIZER INC. ($86.74)

All Payment Transactions

19 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/19/2024 Telix Pharmaceuticals ILLUCCIX (Drug), ILLUCCIX Food and Beverage In-kind items and services $24.30 General
Category: PROSTATE CANCER THERAPY
12/05/2024 Boston Scientific Corporation SpaceOAR VUE System - 10mL (Device) Food and Beverage In-kind items and services $22.11 General
Category: SpaceOAR VUE_URO
11/19/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $17.06 General
Category: HORMONE THERAPY
11/14/2024 PFIZER INC. XTANDI (Drug), TALZENNA, ORGOVYX Food and Beverage In-kind items and services $24.09 General
Category: ONCOLOGY
11/14/2024 Merck Sharp & Dohme LLC LYNPARZA (Biological) Food and Beverage In-kind items and services $13.14 General
Category: ONCOLOGY
11/04/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $18.15 General
Category: Oncology
10/30/2024 Boston Scientific Corporation SpaceOAR VUE System - 10mL (Device) Food and Beverage In-kind items and services $23.11 General
Category: SpaceOAR VUE_URO
10/30/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $18.87 General
Category: Oncology
10/23/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $33.98 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
10/10/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $20.42 General
Category: HORMONE THERAPY
10/07/2024 PFIZER INC. XTANDI (Drug), TALZENNA, ORGOVYX Food and Beverage In-kind items and services $20.55 General
Category: ONCOLOGY
10/03/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $34.59 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
09/30/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $15.09 General
Category: Oncology
09/24/2024 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $23.16 General
Category: HORMONE THERAPY
09/19/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $29.65 General
Category: ONCOLOGY
09/12/2024 PFIZER INC. XTANDI (Drug), TALZENNA, ORGOVYX Food and Beverage In-kind items and services $21.06 General
Category: ONCOLOGY
08/30/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), WELIREG Food and Beverage In-kind items and services $16.40 General
Category: ONCOLOGY
08/29/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $17.03 General
Category: Oncology
08/13/2024 PFIZER INC. XTANDI (Drug), TALZENNA, ORGOVYX Food and Beverage In-kind items and services $21.04 General
Category: ONCOLOGY

About Dr. Jacob Langston, MD

Dr. Jacob Langston, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Homewood, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2019. The National Provider Identifier (NPI) number assigned to this provider is 1508325853.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacob Langston, MD has received a total of $413.80 in payments from pharmaceutical and medical device companies, with $413.80 received in 2024. These payments were reported across 19 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($413.80).

Practice Information

Products in Payments

  • XTANDI (Drug) $86.74
  • PROVENGE (Drug) $68.57
  • ORGOVYX (Drug) $60.64
  • Lenvima (Drug) $50.99
  • KEYTRUDA (Biological) $46.05
  • SpaceOAR VUE System - 10mL (Device) $45.22
  • ILLUCCIX (Drug) $24.30
  • LYNPARZA (Drug) $18.15
  • LYNPARZA (Biological) $13.14

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Homewood